These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dofetilide for atrial fibrillation. Med Lett Drugs Ther; 2000 May; 42(1078):41-2. PubMed ID: 10847114 [No Abstract] [Full Text] [Related]
5. New antiarrhythmic drugs for the treatment of atrial fibrillation. Castro A; Bianconi L; Santini M Pacing Clin Electrophysiol; 2002 Feb; 25(2):249-59. PubMed ID: 11916001 [No Abstract] [Full Text] [Related]
6. A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. Arya A; Silberbauer J; Teichman SL; Milner P; Sulke N; Camm AJ Europace; 2009 Apr; 11(4):458-64. PubMed ID: 19174378 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter. Suttorp MJ; Polak PE; van 't Hof A; Rasmussen HS; Dunselman PH; Kingma JH Am J Cardiol; 1992 Feb; 69(4):417-9. PubMed ID: 1734660 [No Abstract] [Full Text] [Related]
8. [Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency]. Klein HH Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S113-7. PubMed ID: 16921447 [No Abstract] [Full Text] [Related]
9. Dronedarone: where does it fit in the treatment of atrial fibrillation? Clem JR S D Med; 2010 Aug; 63(8):288-9. PubMed ID: 20737996 [No Abstract] [Full Text] [Related]
10. Role of dronedarone in atrial fibrillation: more questions than answers. Hilleman DE; Mooss AN Pharmacotherapy; 2010 Sep; 30(9):867-71. PubMed ID: 20795841 [No Abstract] [Full Text] [Related]
11. Dronedarone (Multaq) for atrial fibrillation. Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011 [TBL] [Abstract][Full Text] [Related]
12. Dofetilide-Induced Severe Hepatotoxicity. Subedi R; Dean RK; Dhamoon AS Am J Ther; 2018; 25(6):e783-e784. PubMed ID: 29912716 [No Abstract] [Full Text] [Related]
13. Dofetilide: is the treatment worse than the disease? Lauer MR J Am Coll Cardiol; 2001 Mar; 37(4):1106-10. PubMed ID: 11263616 [No Abstract] [Full Text] [Related]
14. Dronedarone: from buzz to reality. Le Heuzey JY Arch Cardiovasc Dis; 2010; 103(8-9):427-9. PubMed ID: 21074120 [No Abstract] [Full Text] [Related]
15. A perspective on DIONYSOS. Sahadevan J; Waldo AL J Cardiovasc Electrophysiol; 2010 Jun; 21(6):606-7. PubMed ID: 20455977 [No Abstract] [Full Text] [Related]
18. Dronedarone: is it time to turn it down? Lin L; Bai R Expert Opin Drug Saf; 2013 Jan; 12(1):5-8. PubMed ID: 23137162 [No Abstract] [Full Text] [Related]
19. Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Mykytsey A; Bauman JL; Razminia M; Zheutlin T; Wang T; Saleem M; Leal S; Kehoe RF J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):36-43. PubMed ID: 17495256 [TBL] [Abstract][Full Text] [Related]
20. [The PALLAS study]. Disertori M; Gaita F; Blandino A; Toso E G Ital Cardiol (Rome); 2012 May; 13(5):309-13. PubMed ID: 22539135 [No Abstract] [Full Text] [Related] [Next] [New Search]